Grifols is a pharmaceutical and chemical manufacturer. It operates through four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies. The Bioscience division produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. The Diagnostic division offers a transfusion medicine portfolio as well as specialized clinical diagnostics. The Hospital division provides intravenous and pharmatech solutions, clinical nutrition, and medical devices for interventional therapy. The Bio Supplies division supplies biological materials for life science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products.